Calcium folinate pentahydrate

Gastrointestinal Stromal Tumor

TG Therapeutics, Inc.Small moleculePhase 1Dormant

CCC

52/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 37/ 100
Competitive Position: 95/ 100

Competitive context

2 Active assets in the Gastrointestinal Stromal Tumor cohort.

Asset / Sponsor	Phase	Rating
Imatinib M.D. Anderson Cancer Center	Phase 2	BB
Cediranib National Cancer Institute (NCI)	Phase 2	BB
Ipilimumab National Cancer Institute (NCI)	Phase 2	B
Floxuridine NYU Langone Health	Phase 2	B
Octreotide Pamoate Northwestern University	Phase 2	B

View all 21 →

Same molecule, other indications

Calcium folinate pentahydrate is also rated in:

Advanced KRAS Positive Metastatic Colorectal CancerDormant

BBB

Indicative ·

78 / 100

Recurrent Pancreatic CarcinomaDormant

BBB

Indicative ·

78 / 100

Stage IV Colon CancerDormant

BBB

Indicative ·

77 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.